arXiv · 2611.15071
Improving Efficiency and Power in Small Rare-Disease Trials Through Prespecified, Data-Adaptive Covariate Adjustment
Abstract
Covariate adjustment can potentially improve efficiency in randomized clinical trials, but in rare diseases, limited prior knowledge makes it difficult to specify an adjustment at the design stage. Targeted maximum likelihood estimation (TMLE) with the Super Learner (TMLE+SL) can outperform fixed adjustment methods, such as the G-computation estimator, by leveraging machine learning to learn both the covariates and the functional form of the adjustment from the trial data. Estimating the known treatment mechanism can improve efficiency further. In simulations reflecting real rare-disease trials, TMLE+SL yielded valid inference and achieved greater efficiency and power than conventional analyses. Finally, we also provide practical guidance on specifying TMLE+SL in rare-disease trials.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Tianyue Zhou, Susan Gruber, Hana Lee, Wonyul Lee, Lei Nie, Mark van der Laan. 2026-11-11. Improving Efficiency and Power in Small Rare-Disease Trials Through Prespecified, Data-Adaptive Covariate Adjustment. https://arxiv.science/abs/2611.15071
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite arXiv Science by Indiciae: BibTeX · RIS.